Drug · DIN 00360414
CEENU
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since October 1, 2019; first marketed December 31, 1976.
- Drug Identification Number (DIN)
- 00360414
- Company (DIN owner)
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Lomustine L01AD02
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LOMUSTINE | 100 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 24, 2009: NOC 10060New Drug Submission (NDS) · Manufacturer name change
Other DINs named CEENU
- DIN 00360422 · Marketed
- DIN 00360430 · Marketed